REGISTER NOW TO BECOME A MEMBER

You are viewing the 1st of the 2 courses UPMC Physician Resources permits you to view without registering. To have full access to our FREE courses on our website, please register or log in now.
Register

Lung Cancer 2013 Part 1: Image Guided Ablation to VATS Lobectomy

Publish Date: October 31, 2013 Last Modified: December 22, 2017 Expires: October 31, 2014
This course has been expired.

Drs. David Wilson, Dwight Heron, and Peter Ferson present in part 1 of Lung Cancer 2013: Image Guided Ablation to VATS Lobectomy.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Recognize the role of LDCT in lung cancer screening in 2013
  • Discuss lung cancer risk prediction
  • Discuss the use of DLCO
  • Describe how to evaluate regional lung function
  • Describe selection criteria for early stage NSCLC

Reading Resources:

  1. National Lung Screening Trial Research Team.  Reduced lung cancer mortality with low dose computed tomographic screening.  N Engl J Med 2011;365:395-409.
  2. Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, Luketich JD, Siegfried JM. The Pittsburgh Lung Screening Study (PLuSS); Outcomes within 3 years of a first computed tomography scan. Am J Resp Crit Care Med 2008:178;956-961.
  3. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hseih LJ, Begg CB. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-478.
  4. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM,  Shapiro SD, Sciurba FC.  Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Resp Crit Care Med 2008:178;738-744.
  5. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et al. Benefits and harms of CT screening for lung cancer. JAMA 2012;307.
  6. Loewen, CALGB. J Thoracic Oncology 2007

Disclosures:

Drs. Ferson and Heron have no relevant relationships with any entities producing health care goods or services.

Dr. Wilson has financial interests with the following any entity or entities producing health care goods or services as indicated below:

  • Grant/Research Support: NIH/NCI

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.1) continuing education units (CEU) which are equivalent to 1.0 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 10/31/2013 | Last Modified On: 10/31/2013 | Expires: 10/31/2014

This course has been expired.

Presenters

  • David O Wilson MD MPH
    David O. Wilson, MD MPH
    Dr. Wilson has been associated with the University of Pittsburgh Medical Center since his internship in 1980. He has been on the faculty of both the Graduate School of Public Health and the Medical School at the University of Pittsburgh in one capacity or another since 1986. He currently is at UPMC Shadyside and is the pulmonologist of the Multi-disciplinary Lung Cancer clinic at the Hillman Cancer Center, which he co-founded. Dr. David Wilson is the Director of the Georgia Cooper Lung Nodule/Cancer Proteomics/Genomics Research Registry and Associate Director of the Lung Cancer Center of the Hillman Cancer Center of the University of Pittsburgh Cancer Institute. He is the lead clinician for the Pittsburgh Lung cancer Screening Study (PluSS) and co-investigator for the Pittsburgh Lung Cancer SPORE. He is the principal investigator in Pittsburgh for the Iloprost Chemo-prevention trial. He is the Director of the Nutrition Support Service at UPMC Shadyside. He introduced endobronchial ultrasound (EBUS) to Pittsburgh and has a longstanding interest in lung cancer staging and treatment. Dr. Wilson?s research interests include: lung cancer screening and chemoprevention, diagnosis, staging, and treatment; COPD, especially as it relates to lung cancer; occupational lung diseases; general pulmonary medicine; and nutrition support.
    full profile
  • Peter Ferson MD
    Peter Ferson, MD
    Peter F. Ferson, MD, is a professor of surgery in the Department of Cardiothoracic Surgery. He specializes in all areas of thoracic surgical oncology and the endoscopic and open surgical management of benign and malignant tracheo-bronchial diseases.
    full profile
  • Dwight E Heron MD FACRO
    Dwight E. Heron, MD, FACRO
    Dwight E. Heron, MD, FACRO, FACR, is the chairman of radiation oncology at UPMC Shadyside, vice chairman of radiation oncology at UPCI, director of Radiation Oncology Services at UPMC CancerCenter, and professor of radiation oncology and otololaryngology, head and neck surgery at the University of Pittsburgh School of Medicine.
    full profile

Related Courses